COMPLETE RESPONSE OF CARCINOSARCOMA OF THE OVARY TO THERAPY WITH DOXORUBICIN, IFOSFAMIDE, AND DACARBAZINE

被引:21
作者
SIMON, SR
WANG, SE
UHL, M
SHACKNEY, S
机构
[1] WHEELING MED PK,DEPT MED,WHEELING,WV 26003
[2] ALLEGHENY GEN HOSP,DEPT PATHOL,PITTSBURGH,PA 15212
关键词
D O I
10.1016/0090-8258(91)90278-D
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although carcinosarcoma occurs in various locations throughout the body, it rarely originates in the ovary. Chemotherapy has been minimally beneficial. This case describes a patient with carcinosarcoma of the ovary who responded minimally to chemotherapy used for epithelial carcinomas but had a complete response after receiving chemotherapy used for sarcomas. The patient relapsed within 1 year after receiving cisplatin therapy. She was treated with mesna, ifosfamide, Adriamycin, and dacarbazine (MAID) chemotherapy and after one cycle of chemotherapy she had no evidence of tumor. She has received six cycles of chemotherapy without evidence of progression 13 + months since beginning MAID therapy. MAID chemotherapy may be useful in the treatment of carcinosarcoma of the ovary. © 1991.
引用
收藏
页码:161 / 166
页数:6
相关论文
共 22 条
[1]   PLATINUM-BASED COMBINATION CHEMOTHERAPY FOR MALIGNANT MIXED MESODERMAL TUMORS OF THE OVARY [J].
ANDERSEN, WA ;
YOUNG, DE ;
PETERS, WA ;
SMITH, EB ;
BAGLEY, CM ;
TAYLOR, PT .
GYNECOLOGIC ONCOLOGY, 1989, 32 (03) :319-322
[2]   MALIGNANT MIXED MESODERMAL TUMORS OF THE OVARY - CLINICOPATHOLOGIC ASSESSMENT OF 12 CASES [J].
BARWICK, KW ;
LIVOLSI, VA .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1980, 4 (01) :37-42
[3]  
BRAMWELL V, 1989, J NATL CANCER I, V81, P149
[4]  
CARLSON JA, 1983, CANCER, V52, P1473, DOI 10.1002/1097-0142(19831015)52:8<1473::AID-CNCR2820520823>3.0.CO
[5]  
2-O
[6]   CARCINOSARCOMA AND MIXED MESODERMAL TUMOR OF OVARY - A CLINICOPATHOLOGIC ANALYSIS OF 9 CASES [J].
CZERNOBI.B ;
LABARRE, GC .
OBSTETRICS AND GYNECOLOGY, 1968, 31 (01) :21-&
[7]  
DEHNER LP, 1971, CANCER, V27, P207, DOI 10.1002/1097-0142(197101)27:1<207::AID-CNCR2820270129>3.0.CO
[8]  
2-0
[9]  
DICTOR M, 1985, OBSTET GYNECOL, V65, P720
[10]   RESPONSE TO MESNA, DOXORUBICIN, IFOSFAMIDE, AND DACARBAZINE IN 108 PATIENTS WITH METASTATIC OR UNRESECTABLE SARCOMA AND NO PRIOR CHEMOTHERAPY [J].
ELIAS, A ;
RYAN, L ;
SULKES, A ;
COLLINS, J ;
AISNER, J ;
ANTMAN, KH .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (09) :1208-1216